Described herein are pharmaceutical packaging systems which reduce oxidative degradation of morphine, hydromorphone, promethazine together with other oxygen-sensitive medication, such devices which include a syringe with an oxygen permeable suggestion cap, a hermetically sealed oxygen barrier blister packaging with very low permeability to oxygen a